Statins, fracture risk, and bone remodeling.
1Department of Medical and Surgical Sciences, Division of Endocrionlogy, University of Padua, via Ospedale 105, 35128 Padua, Italy. giovanni.luisetto@unipd.it
Journal of Endocrinological Investigation
|September 3, 2009
Summary
Statins, used to lower cholesterol, may positively impact bone health by enhancing bone formation and density. However, conclusive evidence of their fracture risk reduction in humans requires further randomized controlled trials.
Area of Science:
- Biochemistry
- Pharmacology
- Orthopedics
Background:
- Statins inhibit HMG-CoA reductase, reducing mevalonate formation and cholesterol levels.
- They also inhibit protein prenylation, a critical biological process.
- Research suggests statins influence bone metabolism, affecting bone formation and osteoblast apoptosis.
Purpose of the Study:
- To review the effects of statins on bone formation and remodeling.
- To evaluate the potential of statins in improving bone density and reducing fracture risk.
Main Methods:
- Literature review of studies investigating statin effects on bone metabolism.
- Analysis of in vitro and clinical trial data regarding bone morphogenetic protein-2 (BMP-2), osteoblast apoptosis, osteoclast activity, and bone mineral density.
Main Results:
- Statins demonstrate positive effects on bone formation and decrease osteoblast apoptosis in vitro.
- They inhibit osteoclast activity, potentially uncoupling bone remodeling.
- Patients on statins show higher femoral bone density; lipophilic statins appear more effective.
- Clinical trials show mixed results regarding fracture risk reduction.
Conclusions:
- Statins exhibit beneficial effects on bone in laboratory settings.
- Their clinical efficacy in reducing fracture risk in humans remains uncertain.
- Further randomized controlled trials are necessary to definitively establish the benefits of statins for bone health.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:31Bone Remodeling and Repair
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:27Fractures: Bone Repair
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...